Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 3016 | 167 | 0.1443 | 0.1539 | 0.0554 | 0.0544 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 2637 | 462 | 0.3107 | 0.3034 | 0.1752 | 0.1673 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 1208 | 870 | 0.0483 | 0.0508 | 0.7202 | 0.7144 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 1252 | 898 | 0.0506 | 0.0508 | 0.7173 | 0.7144 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 867 | 41 | 0.6326 | 0.6038 | 0.0473 | 0.0460 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 2626 | 435 | 0.5469 | 0.5260 | 0.1657 | 0.1795 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 2383 | 59 | 0.1177 | 0.1200 | 0.0248 | 0.0313 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 2234 | 406 | 0.4563 | 0.4479 | 0.1817 | 0.1688 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 2185 | 353 | 0.4573 | 0.4479 | 0.1616 | 0.1688 |
A-375 | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 962 | 146 | 0.0413 | 0.0433 | 0.1518 | 0.1382 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 2034 | 549 | 0.3707 | 0.3578 | 0.2699 | 0.2762 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 1078 | 44 | 0.7919 | 0.7554 | 0.0408 | 0.0454 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 653 | 30 | 0.4772 | 0.6038 | 0.0459 | 0.0460 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 2538 | 469 | 0.5165 | 0.5321 | 0.1848 | 0.1853 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 5334 | 374 | 0.2512 | 0.2714 | 0.0701 | 0.0654 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 2659 | 466 | 0.5474 | 0.5321 | 0.1753 | 0.1853 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 2653 | 520 | 0.5325 | 0.5321 | 0.1960 | 0.1853 |
A-375 | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 2 | 1035 | 135 | 0.0456 | 0.0433 | 0.1304 | 0.1382 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 2591 | 461 | 0.5317 | 0.5260 | 0.1779 | 0.1795 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 915 | 46 | 0.6656 | 0.7554 | 0.0503 | 0.0454 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 2484 | 484 | 0.4993 | 0.5260 | 0.1948 | 0.1795 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 2276 | 92 | 0.1106 | 0.1200 | 0.0404 | 0.0313 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 1955 | 588 | 0.3412 | 0.3578 | 0.3008 | 0.2762 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 4220 | 165 | 0.2053 | 0.1658 | 0.0391 | 0.0359 |
A-375 | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 982 | 130 | 0.0431 | 0.0433 | 0.1324 | 0.1382 |